Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.

Authors

Deanna Kerrigan, George Washington University
Miranda Murray
Tahilin Sanchez Karver, George Washington University
Andrea Mantsios
Nicki Walters
Krischan Hudson
Emma Kaplan-Lewis
Federico Pulido
Ayesha Cassim Bassa
David Margolis
Noya Galai

Document Type

Journal Article

Publication Date

3-1-2021

Journal

AIDS Research and Human Retroviruses

Volume

37

Issue

3

Inclusive Pages

207-213

DOI

10.1089/AID.2020.0208

Comments

Epub 2021 Jan 19

APA Citation

Kerrigan, D., Murray, M., Sanchez Karver, T., Mantsios, A., Walters, N., Hudson, K., Kaplan-Lewis, E., Pulido, F., Bassa, A., Margolis, D., & Galai, N. (2021). Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.. AIDS Research and Human Retroviruses, 37 (3). http://dx.doi.org/10.1089/AID.2020.0208

Peer Reviewed

1